✦ LIBER ✦

Comparison of benefit–risk profiles with adalimumab versus etanercept treatment for moderate to severe psoriasis, stratified by weight

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Comparison of benefit–risk profiles for

📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 48 KB

Benefit–risk outcomes with adalimumab ve

📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 47 KB

Cost per responder with adalimumab versu

📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 50 KB

Risk-benefit analysis of adalimumab vers

📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 46 KB

Benefit-risk analysis of adalimumab vers

✍ Kristian Reich; James Signorovitch; Karthik Ramakrishnan; Andrew P. Yu; Eric Q. 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 407 KB